AgomAb Therapeutics N.V. American Shares

AGMB | NASDAQ

$7.46

-$0.03 (-0.40%)

Nov 2, 2026, 10:35 AM ET · Market open

TTM Period Ending	Q2 2026 Jun 30, 2026	Q4 2025 Dec 31, 2025	Q3 2025 Sep 30, 2025	Q4 2024 Dec 31, 2024
Cash & Equivalents	221.59M	86.42M	129.59M	171.46M
Short-Term Investments	30.39M	30.1M	n/a	n/a
Long-Term Investments	13K	11K	11K	12K
Other Long-Term Assets	2.3M	2.15M	2.21M	1.79M
Receivables	n/a	4.09M	n/a	2.12M
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	6.5M	638K	3.43M	267K
Total Current Assets	258.48M	121.24M	133.01M	173.85M
Property-Plant & Equipment	1.41M	1.59M	1.68M	1.99M
Goodwill & Intangibles	28.72M	28.72M	28.72M	28.72M
Total Long-Term Assets	32.44M	32.47M	32.62M	32.51M
Total Assets	290.92M	153.71M	165.63M	206.36M
Account Payables	11.84M	7.63M	7.58M	5.95M
Deferred Revenue	1.26M	1.46M	1.69M	801K
Short-Term Debt	n/a	n/a	n/a	n/a
Other Current Liabilities	6.74M	6.53M	n/a	n/a
Total Current Liabilities	20.07M	18.59M	9.51M	9.13M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	3.44M	3.21M	8.11M	7.88M
Total Long-Term Liabilities	5.48M	4.22M	9.19M	9.15M
Total Liabilities	25.55M	22.8M	18.7M	18.28M
Total Debt	1.14M	1.25M	1.33M	1.55M
Book Value	265.38M	130.9M	146.93M	n/a
Book Value Per Share	5.45	3.08	4.05	n/a
Common Stock	304.62M	223.07M	223.07M	223.07M
Retained Earnings	-212.62M	-181.71M	-164.27M	-119.18M
Comprehensive Income	-14.36M	-967K	-966K	-966K
Shareholders Equity	265.38M	130.9M	146.93M	188.08M
Total Investments	30.4M	30.11M	11K	12K